Regulus Therapeutics | 営業経費



Operating Expenses 変化する 日付
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
AstraZeneca USD 9.91B 2.94B 2025-03
Biogen USD 2.12B 106.5M 2025-03
Celldex Therapeutics USD 63.43M 6.23M 2025-03
Cipla INR 55.01B 1.37B 2025-03
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 8.95M 3.68M 2024-12
CSL USD 5.72B 173M 2024-12
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Grifols EUR 1.6B 128.03M 2024-12
Incyte USD 847.73M 29.46M 2025-03
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
Ligand Pharmaceuticals USD 81.55M 29.1M 2025-03
Merck USD 9.66B 1.67B 2025-03
Sanofi EUR 6.77B 3.75B 2024-12
Takeda JPY 1.13T 51.15B 2025-03



Regulus Therapeutics 営業経費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Jul 2025.